C301-1361 Screening compound: 3-{5-chloro-4-[(3-chlorophenyl)amino]-6-oxo-1,6-dihydropyridazin-1-yl}adamantane-1-carboxylic acid

C301-1361 Screening compound: 3-{5-chloro-4-[(3-chlorophenyl)amino]-6-oxo-1,6-dihydropyridazin-1-yl}adamantane-1-carboxylic acid
C301-1361 Screening compound: 3-{5-chloro-4-[(3-chlorophenyl)amino]-6-oxo-1,6-dihydropyridazin-1-yl}adamantane-1-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound C301-1361
3-{5-chloro-4-[(3-chlorophenyl)amino]-6-oxo-1,6-dihydropyridazin-1-yl}adamantane-1-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C301-1361

Molecular Formula

C21H21Cl2N3O3 (C21 H21 Cl2 N3 O3)

Compound Name

3-{5-chloro-4-[(3-chlorophenyl)amino]-6-oxo-1,6-dihydropyridazin-1-yl}adamantane-1-carboxylic acid

IUPAC name

(5R7S)-3-{5-chloro-4-[(3-chlorophenyl)amino]-6-oxo-16-dihydropyridazin-1-yl}adamantane-1-carboxylic acid

SMILES

OC(C(C[C@@H](C1)C2)(C[C@H]1C1)CC12N(C1=O)N=CC(Nc2cc(Cl)ccc2)=C1Cl)=O

InChI

InChI=1S/C21H21Cl2N3O3/c22-14-2-1-3-15(5-14)25-16-10-24-26(18(27)17(16)23)21-8-12-4-13(9-21)7-20(6-12,11-21)19(28)29/h1-3,5,10,12-13,25H,4,6-9,11H2,(H,28,29)/t12-,13-,20?,21?/m1/s1

InChI Key

HQHPLINDBPLICK-QQRKTFAASA-N

MDL Number (MFCD)

MFCD09696037

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

434.32

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.818

Distribution Coefficient, logD

2.532

Water Solubility, LogSw

-4.61

Polar Surface Area

63.904

Acid Dissociation Constant (pKa)

5.12

Base Dissociation Constant (pKb)

-1.75

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

47.60

C301-1361 in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

CORONAVIRUS Library (20774 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C301-1361 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C301-1361?
Check Price and Availability of C301-1361, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C301-1361 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C301-1361
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C301-1361
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C301-1361 available by request